Nitrofurantoin Monohydrate/ Macrocrystalline (Page 4 of 4)

Storage and Handling

Store at controlled room temperature (59° to 86°F or 15° to 30°C).

Meets USP Dissolution Test 2

Rx Only

REFERENCES

  1. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Eighth Edition. CLSI document M07-A8 [ISBN 1-56238-689-1]. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009.
  2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard- Tenth Edition. CLSI document M02-A 10 [ISBN 1-56238-688-3]. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009.
  3. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. CLSI document M100-S19 [ISBN 1-56238-716-2]. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2010.

CLINICAL STUDIES

Controlled clinical trials comparing Nitrofurantoin monohydrate/macrocrystals capsules 100 mg p.o. q12h and Macrodantin 50 mg p.o. q6h in the treatment of acute uncomplicated urinary tract infections demonstrated approximately 75% microbiologic eradication of susceptible pathogens in each treatment group.

Mfg. By: Norwich Pharmaceuticals, Inc.
6826 State Highway 12
Norwich, NY 13815 USA

Distributed by: Alvogen, Inc.
Pine Brook, NJ 07058 USA

Rev: 06/2012 PI303-03

To report SUSPECTED ADVERSE REACTIONS, contact Alvogen, Inc. at 1-866-770-3024 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nitro 100 Packet
Nitro 100
(click image for full-size original)
Nitro 100
(click image for full-size original)
NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE
nitrofurantoin monohydrate/macrocrystalline capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:58118-0303(NDC:47781-303)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
NITROFURANTOIN (NITROFURANTOIN) NITROFURANTOIN 25 mg
NITROFURANTOIN MONOHYDRATE (NITROFURANTOIN) NITROFURANTOIN 75 mg
Inactive Ingredients
Ingredient Name Strength
CARBOMER 934
STARCH, CORN
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C RED NO. 40
GELATIN
LACTOSE
MAGNESIUM STEARATE
POVIDONE
TALC
TITANIUM DIOXIDE
Product Characteristics
Color YELLOW, BLACK Score no score
Shape CAPSULE Size 20mm
Flavor Imprint Code Macrobid;52427285
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:58118-0303-4 14 CAPSULE in 1 BOTTLE None
2 NDC:58118-0303-2 20 CAPSULE in 1 BOTTLE None
3 NDC:58118-0303-0 1 CAPSULE in 1 PACKET None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020064 05/25/2011
Labeler — Clinical Solutions Wholesale (078710347)
Registrant — Clinical Solutions Wholesale (078710347)
Establishment
Name Address ID/FEI Operations
Clinical Solutions Wholesale 078710347 repack (58118-0303), relabel (58118-0303)

Revised: 08/2013 Clinical Solutions Wholesale

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.